ERRFI1
Ensembl | |||||||||
---|---|---|---|---|---|---|---|---|---|
UniProt | |||||||||
RefSeq (mRNA) | |||||||||
RefSeq (protein) | |||||||||
Location (UCSC) | Chr 1: 8 – 8.03 Mb | Chr 4: 150.94 – 150.95 Mb | |||||||
PubMed search | [3] | [4] |
View/Edit Human | View/Edit Mouse |
ERBB receptor feedback inhibitor 1 is a protein that in humans is encoded by the ERRFI1 gene.[5][6][7][8][9]
MIG6 is a
Cytoplasmic protein whose expression is upregulated with cell growth (Wick et al., 1995). It shares significant homology with the protein product of rat gene-33, which is induced during cell stress and mediates cell signaling (Makkinje et al., 2000; Fiorentino et al., 2000).[9]
Interactions
ERRFI1 has been shown to
References
- ^ a b c GRCh38: Ensembl release 89: ENSG00000116285 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000028967 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ PMID 10749885.
- PMID 2780291.
- S2CID 23762528.
- PMID 11003669.
- ^ a b "Entrez Gene: ERRFI1 ERBB receptor feedback inhibitor 1".
- PMID 15778465.
Further reading
- Zhang YW, Vande Woude GF (March 2007). "Mig-6, signal transduction, stress response and cancer". Cell Cycle. 6 (5): 507–13. PMID 17351343.
- Wick M, Bürger C, Funk M, Müller R (August 1995). "Identification of a novel mitogen-inducible gene (mig-6): regulation during G1 progression and differentiation". Experimental Cell Research. 219 (2): 527–35. PMID 7641805.
- Hackel PO, Gishizky M, Ullrich A (December 2001). "Mig-6 is a negative regulator of the epidermal growth factor receptor signal". Biological Chemistry. 382 (12): 1649–62. S2CID 23424592.
- Tsunoda T, Inokuchi J, Baba I, Okumura K, Naito S, Sasazuki T, Shirasawa S (October 2002). "A novel mechanism of nuclear factor kappaB activation through the binding between inhibitor of nuclear factor-kappaBalpha and the processed NH(2)-terminal region of Mig-6". Cancer Research. 62 (20): 5668–71. PMID 12384522.
- Saarikoski ST, Rivera SP, Hankinson O (October 2002). "Mitogen-inducible gene 6 (MIG-6), adipophilin and tuftelin are inducible by hypoxia". FEBS Letters. 530 (1–3): 186–90. S2CID 37181106.
- Anastasi S, Fiorentino L, Fiorini M, Fraioli R, Sala G, Castellani L, Alemà S, Alimandi M, Segatto O (July 2003). "Feedback inhibition by RALT controls signal output by the ErbB network". Oncogene. 22 (27): 4221–34. S2CID 26020025.
- Xu D, Makkinje A, Kyriakis JM (January 2005). "Gene 33 is an endogenous inhibitor of epidermal growth factor (EGF) receptor signaling and mediates dexamethasone-induced suppression of EGF function". The Journal of Biological Chemistry. 280 (4): 2924–33. PMID 15556944.
- Keeton AB, Messina JL (April 2005). "Modulation of Elk-dependent-transcription by Gene33". Journal of Cellular Biochemistry. 94 (6): 1190–8. S2CID 3023317.
- Benzinger A, Muster N, Koch HB, Yates JR, Hermeking H (June 2005). "Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer". Molecular & Cellular Proteomics. 4 (6): 785–95. PMID 15778465.
- Anastasi S, Sala G, Huiping C, Caprini E, Russo G, Iacovelli S, Lucini F, Ingvarsson S, Segatto O (June 2005). "Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin". Oncogene. 24 (28): 4540–8. PMID 15856022.
- Ballarò C, Ceccarelli S, Tiveron C, Tatangelo L, Salvatore AM, Segatto O, Alemà S (August 2005). "Targeted expression of RALT in mouse skin inhibits epidermal growth factor receptor signalling and generates a Waved-like phenotype". EMBO Reports. 6 (8): 755–61. PMID 16007071.
- Zhang YW, Staal B, Su Y, Swiatek P, Zhao P, Cao B, Resau J, Sigler R, Bronson R, Vande Woude GF (January 2007). "Evidence that MIG-6 is a tumor-suppressor gene". Oncogene. 26 (2): 269–76. PMID 16819504.